Just because it works (preclinically) in ~80% of cell lines doesn't mean it will outperform all existing/future treatment opportunities.
One thing I've noticed across HotCopper is, more often than not, bio investors fail to consider the efficacy of existing treatments.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.35 |
Change
0.080(6.30%) |
Mkt cap ! $234.5M | |||
| Open | High | Low | Value | Volume |
| $1.39 | $1.45 | $1.35 | $317.3K | 229.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 25695 | $1.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.38 | 4775 | 1 |
View Market Depth
| Last trade - 16.10pm 19/06/2025 (20 minute delay) ? |
| RAC (ASX) Chart |